Market Overview

UBS Maintains Neutral on Eli Lilly and Company, Raises PT to $51.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for LLY

DateFirmActionFromTo
Dec 2015Leerink PartnersMaintainsOutperform
Dec 2015Atlantic EquitiesInitiates Coverage onOverweight
Dec 2015Deutsche BankUpgradesHoldBuy

View More Analyst Ratings for LLY
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (LLY)

Get Benzinga's Newsletters